Ron Taylor

Ron Taylor serves as the Sr. Director of Clinical Operations at Curevo Vaccine since February 2024, leveraging extensive experience in the pharmaceutical and biotech industries. Previously, Ron held the position of Sr. Director of Global Clinical Operations at Ultragenyx Pharmaceutical Inc., where responsibilities included strategic planning and oversight of clinical trials in rare disease programs. At Seattle Genetics, Ron managed the Clinical Trial Management team, overseeing over 30 oncology studies globally. Earlier roles include senior leadership positions at Allergan, ICOS Corporation, QLT Inc., and Phoenix International Life Sciences, with a focus on clinical development and research across various therapeutic areas. Ron holds a BSc in Biology from McGill University.